JP2002513813A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002513813A5 JP2002513813A5 JP2000547238A JP2000547238A JP2002513813A5 JP 2002513813 A5 JP2002513813 A5 JP 2002513813A5 JP 2000547238 A JP2000547238 A JP 2000547238A JP 2000547238 A JP2000547238 A JP 2000547238A JP 2002513813 A5 JP2002513813 A5 JP 2002513813A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- type
- papillomavirus
- helicase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101710185720 Putative ethidium bromide resistance protein Proteins 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 108060004795 Methyltransferase Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 241000701806 Human papillomavirus Species 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 241001631646 Papillomaviridae Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000004543 DNA replication Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241000701822 Bovine papillomavirus Species 0.000 description 4
- 241000701646 Kappapapillomavirus 2 Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 241000701447 unidentified baculovirus Species 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 102000003844 DNA helicases Human genes 0.000 description 1
- 108090000133 DNA helicases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101710125507 Integrase/recombinase Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000710961 Semliki Forest virus Species 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8394298P | 1998-05-01 | 1998-05-01 | |
| US60/083,942 | 1998-05-01 | ||
| PCT/CA1999/000389 WO1999057283A1 (en) | 1998-05-01 | 1999-04-28 | Preparation of human papillomavirus e1 having helicase activity and method therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002513813A JP2002513813A (ja) | 2002-05-14 |
| JP2002513813A5 true JP2002513813A5 (enExample) | 2006-06-22 |
Family
ID=22181652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000547238A Pending JP2002513813A (ja) | 1998-05-01 | 1999-04-28 | ヘリカーゼ活性を有するヒトパピローマウイルスｅ１の製剤及びその調製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6306580B1 (enExample) |
| EP (1) | EP1073750A1 (enExample) |
| JP (1) | JP2002513813A (enExample) |
| AU (1) | AU767903B2 (enExample) |
| CA (1) | CA2326402A1 (enExample) |
| HU (1) | HUP0101396A3 (enExample) |
| IL (1) | IL139270A0 (enExample) |
| NZ (1) | NZ508519A (enExample) |
| WO (1) | WO1999057283A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE387500T1 (de) * | 1998-07-21 | 2008-03-15 | Boehringer Ingelheim Ca Ltd | Regionen des papillomavirus-e1-helikase beteiligt an e1 oligomerisierung |
| MXPA01012921A (es) | 1999-06-17 | 2002-09-18 | Boehringer Ingelheim Ltd | Nuevo ensayo de atpasa. |
| GB0017990D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Papilloma virus sequences |
| US7167801B2 (en) | 2001-07-12 | 2007-01-23 | Boehringer Ingelheim (Canada) Ltd. | Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates |
| AU2003215244A1 (en) * | 2002-02-14 | 2003-09-04 | Curagen Corporation | Complexes and methods of using same |
| USD1070308S1 (en) * | 2023-07-13 | 2025-04-15 | Wolverine Outdoors, Inc. | Footwear sole |
| USD1067594S1 (en) * | 2023-07-13 | 2025-03-25 | Wolverine Outdoors, Inc. | Footwear sole |
| USD1067593S1 (en) * | 2023-07-13 | 2025-03-25 | Wolverine Outdoors, Inc. | Footwear sole |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464936A (en) | 1990-12-21 | 1995-11-07 | Cetus Oncology Corporation | Compositions for identification of papillomavirus replication inhibitors |
-
1999
- 1999-04-28 AU AU35923/99A patent/AU767903B2/en not_active Ceased
- 1999-04-28 US US09/300,909 patent/US6306580B1/en not_active Expired - Lifetime
- 1999-04-28 IL IL13927099A patent/IL139270A0/xx unknown
- 1999-04-28 CA CA002326402A patent/CA2326402A1/en not_active Abandoned
- 1999-04-28 EP EP99917722A patent/EP1073750A1/en not_active Withdrawn
- 1999-04-28 HU HU0101396A patent/HUP0101396A3/hu unknown
- 1999-04-28 JP JP2000547238A patent/JP2002513813A/ja active Pending
- 1999-04-28 NZ NZ508519A patent/NZ508519A/en unknown
- 1999-04-28 WO PCT/CA1999/000389 patent/WO1999057283A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vallbracht et al. | Structure-function dissection of pseudorabies virus glycoprotein B fusion loops | |
| Antinone et al. | Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis | |
| Follis et al. | Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell–cell fusion but does not affect virion entry | |
| Klupp et al. | Glycoproteins required for entry are not necessary for egress of pseudorabies virus | |
| Beatch et al. | Rubella virus capsid associates with host cell protein p32 and localizes to mitochondria | |
| AU688887B2 (en) | Novel mutated viruses, anti-viral compounds and novel methods of making vaccines | |
| Seo et al. | Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus | |
| JP2001514879A5 (enExample) | ||
| Philipson et al. | Structure and Function of Virion Proteins of Adenoviruses¹ | |
| JP2002513813A5 (enExample) | ||
| Pettersson et al. | Molecular and Antigenic Characteristics and Synthesis of Rubella Virus Structural. Proteins | |
| AU8783898A (en) | Functional fragments of hiv-1 vpr protein and methods of using the same | |
| EP0970115A1 (en) | Viral peptides with structural homology to protein g of respiratory syncytial virus | |
| Desai et al. | Residues of VP26 of herpes simplex virus type 1 that are required for its interaction with capsids | |
| Selvakumar et al. | Tumor regression is associated with a specific immune response to the E2 protein of cottontail rabbit papillomavirus | |
| JPH10501687A (ja) | ｇｐ３５０／２２０の非スプライシング変異体 | |
| Stewart et al. | In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis | |
| Eron et al. | In vitro synthesis of adenovirus core proteins | |
| CN117157310A (zh) | 针对高致病性冠状病毒的溶细胞性t细胞免疫疗法 | |
| Bowen et al. | Structure of Sendai viral proteins in plasma membranes of virus-infected cells | |
| WO2000009158A1 (en) | Assay for assembly of herpes simplex virus capsid | |
| Soloski et al. | DNA-binding proteins in the cytoplasm of vaccinia virus-infected mouse L-cells | |
| Bagai et al. | A glycine to alanine substitution in the paramyxovirus SV5 fusion peptide increases the initial rate of fusion | |
| Kramer et al. | The head structure of a higher plant V-type H+− ATPase is not always a hexamer but also a pentamer | |
| Rodriguez et al. | NADH-activated cell-free transfer between Golgi apparatus and plasma membranes of rat liver |